Expression of the mRNA coding for plasminogen activator inhibitor (PAI-1) parallels that of 11β-hydroxysteroid dehydrogenase type 1(11β-HSD-1) in adipose tissue of obese patients.

被引：0
|
作者：
Paulmyer-Lacroix, O
Boullu-Ciocca, S
Bastelica, D
Alessi, MC
Dutour, A
Grino, M
机构：
[1] Univ Mediterranee, UFR Med, INSERM,EPI 9936, Hematol Lab, Marseille, France
[2] Univ Mediterranee, Lab Interact Fonct & Neuroendocrinol, Marseille, France
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2004年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [1] Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients:: An in situ hybridization study
    Paulmyer-Lacroix, O
    Boullu, S
    Oliver, C
    Alessi, MC
    Grino, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2701 - 2705
  • [2] 11β-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women
    El Ayachi, S
    Paulmyer-Lacroix, O
    Verdier, M
    Alessi, MC
    Dutour, A
    Grino, M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) : 621 - 627
  • [3] Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)
    Li, Jun
    Kennedy, Lawrence J.
    Walker, Steven J.
    Wang, Haixia
    Li, James J.
    Hong, Zhenqiu
    O'Connor, Stephen P.
    Ye, Xiang-yang
    Chen, Stephanie
    Wu, Shung
    Yoon, David S.
    Nayeem, Akbar
    Camac, Daniel M.
    Ramamurthy, Vidhyashankar
    Morin, Paul E.
    Sheriff, Steven
    Wang, Mengmeng
    Harper, Timothy W.
    Golla, Rajasree
    Seethala, Ramakrishna
    Harrity, Thomas
    Ponticiello, Randolph P.
    Morgan, Nathan N.
    Taylor, Joseph R.
    Zebo, Rachel
    Maxwell, Brad
    Moulin, Frederick
    Gordon, David A.
    Robl, Jeffrey A.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (12): : 1170 - 1174
  • [4] 11β-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients
    Desbriere, Raoul
    Vuaroqueaux, Vincent
    Achard, Vincent
    Boullu-Ciocca, Sandrine
    Labuhn, Martin
    Dutour, Anne
    Grino, Michel
    [J]. OBESITY, 2006, 14 (05): : 794 - 798
  • [5] Use of a 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1) inhibitor to assess the contribution of the viscera and liver to splanchnic cortisol production
    Basu, Rita
    Edgerton, Dale
    Link, J. T.
    Wang, J.
    Jacobson, Peer
    Singh, Ravinder J.
    Toffolo, Gianna
    Cobelli, Claudio
    Cherrington, Alan
    Rizza, Robert A.
    [J]. DIABETES, 2007, 56 : A678 - A678
  • [6] Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism
    Shelest, A.
    Matveeva, M. A.
    Popova, L., V
    Patrushev, L., I
    Shuganov, E. G.
    Gneusheva, T. Y.
    Bokarev, I. N.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1173 - 1173
  • [7] 11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
    Munoz, Rodrigo
    Carvajal, Cristian
    Escalona, Alex
    Boza, Camilo
    Perez, Gustavo
    Ibanez, Luis
    Fardella, Carlos
    [J]. OBESITY SURGERY, 2009, 19 (06) : 764 - 770
  • [8] 11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
    Rodrigo Muñoz
    Cristian Carvajal
    Alex Escalona
    Camilo Boza
    Gustavo Pérez
    Luis Ibáñez
    Carlos Fardella
    [J]. Obesity Surgery, 2009, 19 : 764 - 770
  • [9] Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects
    Koistinen, HA
    Dusserre, E
    Ebeling, P
    Vallier, P
    Koivisto, VA
    Vidal, H
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2000, 16 (05) : 364 - 369
  • [10] 11β-hydroxysteroid dehydrogenase type 1 (11-HSD-1) activities in patients with hypopituitarism
    Kobayashi, Y
    Tagawa, N
    Ikariko, N
    Imamura, T
    Higashide, T
    Mori, H
    Inada, H
    Yamano, T
    [J]. CLINICAL CHEMISTRY, 2005, 51 : A226 - A226
12345